trends Thanks when will non-GAAP of quarter for underlying today's joining year the most XXXX to financial to you on applicable, the impacting the release description detailed year results, and our all full into XXXX our everyone. insight and as us GAAP items more Ben our press QX and good for the fourth refer forma I Please Thank these for results. my pro of businesses. focus afternoon a today. comments full provide
in net X% in year-over-year Covetrus and XXXX. increased just $X XXXX. over for the X% net $X.X Non-GAAP QX organic full pro approximately were and year sales QX forma billion in sales billion year-over-year
foreign exchange pro Choice As and normalizes in our First the to comparisons. includes periods manufacturer forma to from the U.S., M&A reminder, which of and Vets fluctuations adjustments growth sales can a switches in non-GAAP organic impact net impact both sales excludes for direct year-over-year agency sales
loss of quarter These X% these fourth forma North model manufacturer underlying organic that the previously growth from the in QX for approached is in and the XXXX. the moving direct for Pacific to XXXX. would results impact APAC, the sales announced have a full Asia include impact during and sales customer to Normalizing a events, in net tied X% two pro of year America
QX year our negatively increased by full chain previously operating the of America America North organic supply loss X% customer, announced in in full sales and growth The segment both impacted organic performance, year-over-year net QX year. X% North to for X% pro the Moving net a forma and sales XXXX.
softer Our QX growth modestly visit growing. excluded. when market decreased is veterinary organic versus increased the year-over-year in growth announced remains QX net practice and in stable general QX X% in chain Overall in pro patient or loss North modestly But America. customer supply sales was forma previously the
America For forma X% the chain specific organic increased from impact North sales this our net of growth customer XXXX, loss. when supply excluding all have in pro would
of in than ended Total practices Vets with practices. management more $XXX XX,XXX goal platform We the $XX First and year-over-year XXXX QX our prescription in XX% Choice increased XX,XXX least our achieving XX% on at sales million ending to XXXX. net year with to million year-over-year
growth have continue driving our sales we delivered as in to XXXX. base. customer approximately in we success from enrollments same-store existing XX% And Ben new mentioned, Beyond growth year-over-year
our during of date which to year-over-year XXXX all to grow digits back Importantly cohorts XXXX. double continued
sales full year-over-year forma the for Pro organic in and increased Europe. net X% QX X% year-over-year year XXXX. to Turning
in forma market pro QX. U.K. our which largest is net European X% organic year-over-year Our sales increased
Our U.K. a as the the group call from of business relationship continues on our execution to team. expansion we corporate which with benefit continued large solid QX, announced as by our XXXX well
our of healthy growth in net experienced forma also pro in sales Ireland, European and markets businesses Czech performances most Republic. Poland other strong the our We from organic including operating
in and the X% direct full QX APAC the to Normalizing year-over-year organic year of markets on the X% in an sales a pro Brazil. impact strong and team and our continued went XXXX. model that and delivered in manufacturer Moving net the increase New in forma market and markets sales number APAC emerging for to for of the XX% XXXX full X% driven for segment this the Zealand QX in grew growth in emerging year-over-year performance November by and in year served customers a XXXX,
financial continues execute results. Overall to robust this and team well deliver
Before will net provide the remain we business. P&L, that delivering on I investment We committed wanted hope by for drivers be filed software lines of which will geography the useful. including on supply will to which our annual sales prescription Form management to the transparency our find soon the core increased rest our share moving of business XX-K to also details community chain, and
Turning in selling Choice business our was to cost from we Vets shipping goods In administrative sold the to and be GAAP consolidated gross changed classification rest general the versus First in of our QX consistent prior of expense gross at year of to XX.X% expense business. legacy QX the the margin with the margin, XX.X% period.
expense EBITDA. $X and classification the shift sold selling $XX administrative impact no classification of QX And million an the represented first was of to XXXX, on adjusted a for million nine general In the There months approximately represented shift. cost goods expense. from
would the QX as includes First and to Vets excludes classification margin XX.X% XXXX the been period prior prior the forma change a On year to gross Choice basis have which XX.X% our year. in pro in compared
offset forma margin compared pro For been proprietary the prescription margin year XX.X% in higher-margin our and platform growth supply products XX.X% the pressure our in the have as management moderate including full chain. XXXX, by services were gross as would year in prior to
and were of special Our GAAP million XXXX. being investments during ramping million during tied separation of selling operating of the general the quarter $XXX certain of public to the merger, fourth and year company. a the impact $XXX infrastructure expenses the and and cost full and expenses includes stand-alone administrative This the XXXX items
fourth non-GAAP an by Non-GAAP the in not year-over-year was supply quarter adjusted chain profitability, and period versus was $X EBITDA foreign $XX that Europe the a general forma prior year administrative certain in changes American pro million in basis year a headwind The XX% a decrease selling general million of on expenses, on did million in basis. negative exchange. lower from XXXX to million prior the North for non-GAAP corporate XXXX a tied pro in in $XX the driven and impact forma recur $X and administrative results benefits overall increase
the growth markets the in XXXX These of headwinds Vets profitability, modest emerging acquisitions XXXX. underlying offset during improvement First fourth organic contribution and year-over-year Choice APAC and quarter the from in
year-over-year the year-over-year as described. emerging just result while exchange foreign America growth, and of adjusted North G&A and Europe On dynamics and a witnessed markets a EBITDA APAC segment basis declined
pro For $XXX forma million non-GAAP the in million versus $XXX EBITDA full the was year adjusted full year for XXXX. XXXX
the we rest Looking had approximately in million income interest the $XX of in statement, expense net QX. at
XXXX. of full Non-GAAP QX versus was Our net share $XX on loss a and loss of or loss income forma $X GAAP period. in $XX the adjusted a million, prior share or year per the QX million year diluted billion, for $X.XX per million pro diluted per $X.XX during basis net a was $XX share
was forma For in $XX non-GAAP the decline the impacted adjusted year XXXX. by million in million forma in non-GAAP net $XX aforementioned pro adjusted the full EBITDA pro XXXX, versus income prior year
XXXX property facility. revolving metrics. $XX and cash million with operations and XXXX sheet flow no flow cash from debt cash $XX $XXX equivalents and billion cash to in million $XXX of equipment Turning credit balance and of non-GAAP million. against Covetrus free QX purchases in $X.X million ended We in and borrowings in million net generated flow, during subtracting the $XXX cash our when
XX, times inside of X.X well Our credit week, agreement XXXX ratio the as net XX mentioned last stood X.X by defined our earlier, the our covenant was we ended the at to Ben June XX, scheduled with months amended ratio step into times EBITDA December as an late into trailing XXXX. debt the leverage go syndicate that down entered ended agreement our And covenant. regarding for lenders approximately adjusted quarter net effect of to for
Under ended XXXX. leverage the the fourth to net full have the one now for XX, amended we out – with June beginning year step our quarter down of the adjusted terms, to times X.X net with drop the with pushed bank-defined EBITDA debt covenant
Additional in that to Form we this included be today. XX-K plan annual details file of amendment will our
Also of to the The XX, sell of the transaction to year our purposes, And is amortization The we health announced required through credit our quarter reinvesting mandatory Heska payments. business to used the into million. for the business. close quarters to cash be including remaining scil about agreement proceeds the of debt general for under to a of including use expected on net QX payment on X. March end, down will subsequent to pay $XXX for quarterly or debt, plan animal million prepayment of principal balance the including corporate $XX the definitive back care agreement April the we QX
net XXXX $X.XXX billion XXXX novel sales so again forecast health for significant $X.XXX economic the our and or coronavirus to sales. our and $X.XXX that repeating Turning chain of a assumes joint second billion divestiture to both disruption S.A. billion, disease guidance, the venture We which related XXXX to net no quarter animal Distrivet impact $X.XXX the scil COVID-XX. care close with to forecast that XXXX billion supply or
X% outlook growth current forma from and X%, the and foreign XXXX Embedded impact our non-GAAP transactions. M&A net exchange organic previously XXXX of is pro rates in activity this sales to announced the in
performance chain prescription modest incorporates management trends outside outlook our business strong supply American our platform expectations for in the and continued Our organic U.S. underlying North healthy
our Turning range non-GAAP so care year-over-year $XXX EBITDA million are results to $XXX relatively the million the of was guidance animal over EBITDA approximately growth forma XXXX pro adjusted to excluding million. million, animal adjusted the forma XXXX of non-GAAP excluding XXXX when business. The scil EBITDA In EBITDA, $XXX in to $XXX adjusted million. pro scil flattish forecasting our $XXX we reflects midpoint the business care XXXX, adjusted
wanted against the our the our community associated into Underlying all set at a the we investment to from with delivering confidence until the expectations I to ramp seek more business, XXXX in overhead XXXX. not gate. stand-alone commitment going begin did we growth Before build the details, continue to XXXX a to as investor out for investments by reiterate level after of just challenging which start forth the to is in timing offset impact late geographies segment corporate QX running to
quarter comparisons XXXX of you year. guidance, we should would overhead the our provide adjusted result, keep not our investments timing outlook. of given as quarterly specific QX And most represents While that out EBITDA year difficult we point approximately last a do QX year-over-year the XX% first full to
creates period. comparable headwind year-over-year compared the mind million QX $XX operating balance year when our compared the average of year. expenses $XX continuing This were in and million to $X as quarter an in XXXX this per overhead with QX to XXXX over million that results this approximate dynamic into approximately a of Keep adjusted the corporate
drive to as operating our better leverage from progress the expect expenses through corporate the year. adjusted We of operating balance we
provision as analyze plans are shortly review the associated to company's weakness expanded XXXX. issues and will remediation our further tax and balances, more for XX-K deferred general the taxes These implementation establishing controls impacted the disclosed a material has annual by the to as to income report information well in this transition controls issue, filed technology for quarter tax with in disclosed income new and that and the Lastly, related tax in-house of last management our capabilities. issues be identified Form identified underway caused as
remarks. over Now, turn some I'll closing Ben for this brief back to